Financials Innova Captab Limited

Equities

INNOVACAP

INE0DUT01020

Pharmaceuticals

Market Closed - NSE India S.E. 05:13:53 24/05/2024 pm IST 5-day change 1st Jan Change
485.8 INR -2.11% Intraday chart for Innova Captab Limited -3.33% -10.27%

Income Statement Evolution (Annual data)

Fiscal Period: März 2018 2019 2020 2021 2022 2023
Net sales 1 2,362 3,570 3,702 4,107 8,005 9,264
EBITDA 1 321.9 400.6 476.6 541.4 956.1 1,148
EBIT 1 210.7 293.9 376.9 489.4 885.7 1,047
Operating Margin 8.92% 8.23% 10.18% 11.92% 11.06% 11.3%
Earnings before Tax (EBT) 1 161.7 240.3 345.5 463.4 857.2 918
Net income 1 119.4 191.8 258.6 345 639.5 679.5
Net margin 5.05% 5.37% 6.99% 8.4% 7.99% 7.34%
EPS 2 2.487 3.996 5.388 7.188 13.32 14.16
Free Cash Flow - 9.449 159.7 160.8 -1,456 -587.2
FCF margin - 0.26% 4.32% 3.91% -18.18% -6.34%
FCF Conversion (EBITDA) - 2.36% 33.51% 29.69% - -
FCF Conversion (Net income) - 4.93% 61.76% 46.6% - -
Dividend per Share - - - - - -
Announcement Date 02/09/19 02/09/19 25/11/20 30/11/21 30/09/22 13/09/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 758 705 499 407 1,983 2,299
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 2.354 x 1.76 x 1.048 x 0.7518 x 2.074 x 2.002 x
Free Cash Flow - 9.45 160 161 -1,456 -587
ROE (net income / shareholders' equity) - 26.5% 27.2% 27% 36.2% 27.6%
ROA (Net income/ Total Assets) - 8.54% 10.1% 9.95% 11.7% 10.2%
Assets 1 - 2,246 2,561 3,466 5,460 6,644
Book Value Per Share 2 13.00 17.10 22.50 30.20 43.50 57.60
Cash Flow per Share 2 0.0400 0.1700 0.5400 1.000 0.0300 0.7300
Capex 1 147 86.4 41 187 799 790
Capex / Sales 6.24% 2.42% 1.11% 4.56% 9.98% 8.53%
Announcement Date 02/09/19 02/09/19 25/11/20 30/11/21 30/09/22 13/09/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. INNOVACAP Stock
  4. Financials Innova Captab Limited